Drug · DIN 02245283
FXT 40
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 3, 2011; first marketed June 21, 2002.
- Drug Identification Number (DIN)
- 02245283
- Company (DIN owner)
- Sepracor Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Fluoxetine N06AB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUOXETINE (FLUOXETINE HYDROCHLORIDE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 11, 2009: NOC 10584Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- January 11, 2002: NOC 557Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change